HOME › DRUGS › NEPAFENAC
ACTIVE SUBSTANCE / INN

NEPAFENAC

Brand name(s): ILEVRO, Nevanac, NEVANAC
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA021862
Pain, Postoperative;Ophthalmologic Surgical Procedures
ACTIVE SUBSTANCE
Nepafenac
REGULATORS
FDA · EMA
SPONSORS / MAH
HARROW EYE, Novartis Europharm Limited
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NEVANACNDA021862HARROW EYEPrescription
ILEVRONDA203491HARROW EYEPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NevanacNovartis Europharm LimitedAuthorised11/12/2007Pain, Postoperative;Ophthalmologic Surgical Procedures

FULL INTELLIGENCE ON NEPAFENAC

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →